Stratasys said its TrueDent resins received CE marking as a Class IIa medical device under the EU Medical Device Regulation. The certification expands the indication to intraoral removables for long-term use of more than 30 days, as well as crowns and bridges. Stratasys said the European denture market was USD 2.19 billion in 2023 and is projected to reach USD 2.45 billion by 2028.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stratasys Ltd. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260317920719) on March 17, 2026, and is solely responsible for the information contained therein.
Comments